The dominant risk is pigmentary injury: ablative CO₂ resurfacing in Fitzpatrick phototypes III–V carries a substantially higher risk of post-inflammatory hyperpigmentation (PIH) than in fair skin, along with thermal burns, prolonged erythema and edema, hypopigmentation, and scarring. PIH may appear about one month after treatment and become most pronounced over the following several months; delayed permanent hypopigmentation can occur much later.
In non-white patients, the safest approach is to minimize unnecessary thermal and epidermal injury: select appropriate candidates, favor fractional delivery when clinically suitable, use conservative and individualized parameters, and maintain rigorous pre- and post-treatment skin management.
The Main Risks Practitioners Must Manage
Post-inflammatory hyperpigmentation
PIH is the principal complication in darker phototypes. The primary reference reports PIH in approximately 25–68% of non-white patients, compared with roughly 3–7% in fair-skinned patients.
PIH commonly develops around one month after treatment and may become most prominent within approximately four months. Patients should be counseled that pigment changes may persist and may require prolonged management.
Hypopigmentation
Ablative treatment can also produce hypopigmentation, including delayed and potentially permanent loss of pigment. This risk is particularly important as skin phototype increases and may become evident well after the initial healing period, reportedly up to 18 months after treatment.
Hypopigmentation can be difficult to reverse and may be more conspicuous than transient hyperpigmentation.
Thermal burns and excessive tissue injury
Higher melanin content increases the risk that thermal exposure will produce unwanted epidermal injury. Inappropriate fluence, pulse duration, coverage, or overlap can cause burning, blistering, prolonged inflammation, and scarring.
Laser-tissue interaction is immediate, so operators cannot safely rely on adjusting the dose after injury has occurred. Facial areas require especially conservative decision-making because damage may be irreversible.
Scarring and delayed recovery
Excessive thermal injury or overly aggressive coverage can increase the risk of atrophic or hypertrophic scarring. It can also prolong erythema, edema, barrier disruption, and recovery.
These risks are not limited to patients with the darkest skin. Fitzpatrick III, particularly darker type III, should not automatically be treated using parameters intended for types I–II.
Why CO₂ Resurfacing Is More Challenging in Phototypes III–V
Ablation disrupts the epidermal barrier
Ablative CO₂ lasers at 10,600 nm target water and vaporize treated epidermal and dermal tissue. This produces substantial remodeling but also creates more epidermal disruption and thermal stress than less aggressive approaches.
In darker skin, the inflammatory response and melanocyte stimulation associated with this injury can produce clinically significant dyschromia.
Fractional treatment preserves intervening skin
Fractional CO₂ systems create microscopic treatment zones separated by untreated tissue. The intact areas help preserve barrier function, support faster healing, and generally reduce the severity of pigmentary complications compared with nonfractionated full-field ablation.
Fractional treatment lowers risk; it does not eliminate it. Phototypes III–V still require individualized settings and careful follow-up.
Thermal confinement is central
The operator should apply the principles of selective photothermolysis and thermal confinement: deliver sufficient energy to the intended target while limiting heat diffusion and unnecessary vaporization of surrounding tissue.
Pulse width, energy density, treatment density, and overlap all influence the amount and depth of thermal injury. These variables must be considered together rather than adjusted in isolation.
Risk Management Before Treatment
Perform a precise baseline assessment
Document the patient’s Fitzpatrick phototype, current pigmentation, history of PIH or hypopigmentation, tendency toward abnormal scarring, and any active inflammatory skin condition.
Baseline photographs and documentation of pre-existing dyschromia are important because post-treatment color changes may evolve gradually.
Select patients and treatment goals carefully
High-energy, fully ablative resurfacing is most predictable in phototypes I–II and lighter type III. Treatment in phototypes III–V may still be appropriate, but the threshold for selecting a fractional or less aggressive approach should be lower.
For severe rhytids or scarring, the practitioner should weigh whether the expected benefit justifies the increased pigmentary and scarring risk.
Consider a test spot
For darker skin candidates, a small test area—approximately 2 × 2 cm, where clinically appropriate—can help assess the patient’s thermal and pigmentary response before broader treatment.
A test spot is not a guarantee of safety. Delayed PIH and hypopigmentation may not be fully predicted by an early response.
Establish a skin-management plan
Patients should receive clear pre- and post-procedure instructions, including strict sun protection and appropriate management of inflammation and barrier disruption.
They should also understand that pigment alteration may emerge weeks after treatment and that follow-up is necessary even when early healing appears satisfactory.
Risk Management During Treatment
Use conservative fluence and coverage
Energy density and coverage should be individualized to the patient’s phototype, treatment indication, anatomic site, and selected delivery mode. In phototypes III–V, the objective is to achieve the clinical endpoint with the lowest effective thermal burden.
Avoid assuming that a setting appropriate for lighter skin will be safe for darker skin, even when the treatment area and indication are similar.
Control pulse duration and thermal diffusion
For fractional CO₂ treatment, careful adjustment of pulse width and overlap helps control thermal diffusion and treatment density. The supplementary reference identifies pulse widths in the approximate 800–1000 microsecond range as a technical consideration, but settings must remain device-specific and clinically individualized.
Shorter or otherwise optimized energy delivery should not be treated as a substitute for conservative fluence and appropriate coverage.
Limit excessive overlap and density
Repeated passes, high overlap, and excessive treatment density increase cumulative thermal injury. These factors should be limited unless there is a compelling clinical reason and the practitioner has carefully assessed the additional risk.
The safest plan is not necessarily the most aggressive plan; staged treatment may be preferable when the desired endpoint would otherwise require excessive injury in a single session.
Use appropriate cooling
Cooling can help protect the surrounding epidermis and reduce unwanted thermal accumulation. It should complement—not replace—appropriate fluence, pulse duration, spacing, and coverage decisions.
The cooling method must be compatible with the device and treatment protocol, since inadequate or poorly controlled cooling may fail to prevent injury.
Understanding the Trade-offs
More aggressive resurfacing may produce greater remodeling
Higher-energy, denser, nonfractionated treatment can create more substantial ablation and potentially greater resurfacing effects. It also increases epidermal disruption, recovery time, and the risk of PIH, hypopigmentation, burns, and scarring.
In phototypes III–V, a less aggressive or staged approach may provide a better overall risk–benefit balance.
Fractional treatment is safer, not risk-free
Fractional delivery preserves islands of untreated skin and generally reduces severe pigmentary complications. However, excessive fluence, density, overlap, or pulse duration can still cause significant thermal injury.
Fractional treatment should therefore be viewed as a risk-reduction strategy rather than a guarantee against dyschromia.
Conservative settings may require additional sessions
Lower energy and reduced coverage can limit complications but may produce less dramatic immediate resurfacing. Patients may need realistic expectations regarding gradual improvement, staged treatment, or a less complete single-session result.
That trade-off is often preferable to causing a pigmentary complication that is difficult to correct.
Delayed complications require long-term surveillance
Early erythema and edema are visible soon after treatment, but PIH and hypopigmentation may evolve later. Follow-up should extend beyond the initial healing period, particularly in phototypes IV and V.
Patients should be told to report new or worsening pigmentation rather than waiting for the next routine appointment.
Making the Right Choice for Your Goal
The treatment plan should be based on the patient’s desired outcome, risk tolerance, and baseline pigmentary behavior.
- If your primary focus is minimizing PIH: Favor fractional delivery when clinically suitable, use conservative fluence and coverage, control pulse duration and overlap, protect the epidermis with appropriate cooling, and enforce strict sun protection.
- If your primary focus is treating severe rhytids or scarring: Consider whether staged fractional treatment or a test spot offers a safer balance than high-energy full-field ablation.
- If your primary focus is preventing permanent pigment loss: Counsel explicitly about delayed hypopigmentation, avoid excessive thermal injury, and maintain follow-up well beyond the early healing period.
- If your primary focus is selecting candidates safely: Assess phototype, baseline pigmentation, prior PIH or scarring, and the patient’s ability to follow prolonged sun-protection and aftercare instructions.
For Fitzpatrick III–V patients, successful CO₂ resurfacing depends on controlling thermal injury as carefully as achieving the intended resurfacing effect.
Summary Table:
| Risk | Prevalence in III–V | Onset | Key Management |
|---|---|---|---|
| Post-inflammatory hyperpigmentation (PIH) | 25–68% | ~1 month, peaks ~4 months | Use fractional delivery, conservative fluence, strict sun protection |
| Hypopigmentation | Not specified, but risk increases with phototype | Up to 18 months | Avoid excessive thermal injury, long-term surveillance |
| Thermal burns & excessive tissue injury | High due to melanin | Immediate | Conservative parameters, limited overlap, cooling |
| Scarring & delayed recovery | Increased with aggressive treatment | Immediate to weeks | Staged treatment, test spot, proper wound care |
Elevate your practice with advanced CO2 laser systems from BELIS. Our medical-grade equipment is designed for clinics and premium salons, ensuring safety and efficacy for all skin types. Discover our range of aesthetic lasers and body sculpting devices. Contact us today to learn how BELIS can enhance your treatment outcomes and patient satisfaction.
Related Products
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- How do energy-based modalities complement injectable neurotoxins in décolleté rejuvenation? Explore synergistic benefits.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
